openPR Logo
Press release

Investigation announced for Investors in shares of Stem, Inc. (NYSE: STEM) over potential Wrongdoing

02-17-2023 01:57 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of investors in Stem, Inc. (NYSE: STEM) shares over potential wrongdoing at Stem, Inc. was announced.

An investigation on behalf of investors in Stem, Inc. (NYSE: STEM) shares over potential wrongdoing at Stem, Inc. was announced.

An investigation on behalf of investors in shares of Stem, Inc. (NYSE: STEM) was announced over potential breaches of fiduciary duties by certain officers and directors at Stem, Inc.

Investors who purchased shares of Stem, Inc. (NYSE: STEM) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Stem, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.

San Francisco, CA based Stem, Inc. operates as a digitally connected and intelligent energy storage network provider in the United States and internationally. Stem, Inc. reported that its annual Total Revenue rose from $36.3 million in 2020 to $127.37 million in 2021, and that its Net Loss declined from $156.12 million in 2020 to $101.21 million in 2021.

On January 11, 2023, Blue Orca Capital issued a short report alleging multiple claims. The report claims that it has uncovered "undisclosed to investors, STEM is financing its flagship customer to purchase energy storage systems from STEM. Rather than a "big win" and proof that STEM could compete for big utility scale projects, we think STEM won its supposed flagship deal by surreptitiously paying for it."

Shares of Stem, Inc. (NYSE: STEM) declined from $9.40 per share on January 10, 2023, to $8.35 per share on January 11, 2023. Since then shares of Stem, Inc. (NYSE: STEM) rose to $11.00 per share on January 18, 2023.

Those who purchased shares of Stem, Inc. (NYSE: STEM) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in shares of Stem, Inc. (NYSE: STEM) over potential Wrongdoing here

News-ID: 2934862 • Views:

More Releases from Shareholders Foundation

ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly NASDAQ: SINA)
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made. If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: FLR) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements. Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp. (NYSE: SOC)
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp. Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc. (NASDAQ: LNTH)
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com

All 5 Releases


More Releases for Stem

Animal Stem Cell Therapy Market Worth Observing Growth| Cell Therapy Sciences, M …
Advance Market Analytics published a new research publication on "Animal Stem Cell Therapy Market Insights, to 2030" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Animal Stem Cell Therapy market was mainly driven by the increasing R&D spending across the world. Some of
Introducing My STEM Resume: The Ultimate Solution for STEM Professionals
As STEM industries continue to grow, so does the demand for qualified professionals. Yet, many STEM students and professionals face challenges in effectively showcasing their skills and experience to prospective employers. Recognizing this need, Brendon, a seasoned STEM professional, has developed a groundbreaking solution: My STEM Resume. My STEM Resume is a cutting-edge app designed specifically for STEM professionals, offering a comprehensive suite of tools to streamline the resume creation and
Animal Stem Cell Therapy Market 2022: Allogeneic Stem Cells Popular Sourcing Cho …
The global animal stem cell therapy market recorded sales of around US$ 249.9 Mn in 2021 and the market is predicted to experience healthy growth over the years ahead at a CAGR of 5.2% (2022 to 2032). Request For Free Sample Report of "Animal Stem Cell Therapy Market"@ https://www.persistencemarketresearch.com/samples/14941 Animal stem cell therapies are treatments for disorders such as arthritis, soft tissue injuries, traumatic fractures, tendonitis, inflammatory bowel disease, and others that
Animal Stem Cell Therapy Market 2021 Research Report by Experts- Magellan Stem C …
Global Animal Stem Cell Therapy Market Size, Status and Forecast 2022 The Global Animal Stem Cell Therapy Market Research Report 2022-2027 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive
Stem Cells Market: Development of Infrastructure to Drive Global Stem Cells Mark …
In the global stem cells market a sizeable proportion of companies are trying to garner investments from organizations based overseas. This is one of the strategies leveraged by them to grow their market share. Further, they are also forging partnerships with pharmaceutical organizations to up revenues. Read Report Overview - https://www.transparencymarketresearch.com/stem-cells-market.html In addition, companies in the global stem cells market are pouring money into expansion through multidisciplinary and multi-sector collaboration for large
Global Animal Stem Cell Therapy Market Detailed Analysis 2018-2025 : MediVet Bio …
Qyresearchreports include new market research report “Global Animal Stem Cell Therapy Market Research Report 2018” to its huge collection of research reports. Animal stem cell therapy is a usage of animals stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process